肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 BSH指南：唐氏综合征一过性白血病的调查和管理

2018-06-19 英国血液病学学会 British Journal of Haematology.19 June 2018.

唐氏综合征一过性白血病

2018年6月，英国血液病学学会(BSH)发布了唐氏综合征一过性白血病的调查和管理指南，本文的主要目的是针对唐氏综合征一过性白血病的调查和管理提供指导建议，内容涉及唐氏综合征一过性白血病的定义，临床标准和诊断，筛查，结局，危险因素，监测等。

中文标题：

2018 BSH指南：唐氏综合征一过性白血病的调查和管理

英文标题：

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome

发布机构：

英国血液病学学会

发布日期：

2018-06-19

简要介绍：

2018年6月，英国血液病学学会(BSH)发布了唐氏综合征一过性白血病的调查和管理指南，本文的主要目的是针对唐氏综合征一过性白血病的调查和管理提供指导建议，内容涉及唐氏综合征一过性白血病的定义，临床标准和诊断，筛查，结局，危险因素，监测等。 

拓展指南：与白血病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 BSH指南：唐氏综合征一过性白血病的调查和管理)] GetToolGuiderByIdResponse(projectId=1, id=682381c00160e143, title=2018 BSH指南：唐氏综合征一过性白血病的调查和管理, enTitle=Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome, guiderFrom=British Journal of Haematology.19 June 2018., authorId=null, author=, summary=2018年6月，英国血液病学学会(BSH)发布了唐氏综合征一过性白血病的调查和管理指南，本文的主要目的是针对唐氏综合征一过性白血病的调查和管理提供指导建议，内容涉及唐氏综合征一过性白血病的定义，临床标准和诊断，筛查，结局，危险因素，监测等。 , cover=, journalId=null, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jun 19 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年6月，英国血液病学学会(BSH)发布了唐氏综合征一过性白血病的调查和管理指南，本文的主要目的是针对唐氏综合征一过性白血病的调查和管理提供指导建议，内容涉及唐氏综合征一过性白血病的定义，临床标准和诊断，筛查，结局，危险因素，监测等。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">白血病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=5c8f51c00158888f" title="2018 法国慢性粒细胞白血病研究组实践建议：酪氨酸激酶抑制剂治疗慢性粒细胞白血病的停药" target="_blank">2018 法国慢性粒细胞白血病研究组实践建议：酪氨酸激酶抑制剂治疗慢性粒细胞白血病的停药</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=26a2d1c0015e5365" title="中国蒽环类药物在白血病治疗中的临床应用专家共识" target="_blank">中国蒽环类药物在白血病治疗中的临床应用专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c46081c0015ea969" title="NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）" target="_blank">NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=586e11c0015e180c" title="NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）" target="_blank">NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=232d41c0015631d5" title="NCCN临床实践指南：急性髓性白血病（2018.V1）" target="_blank">NCCN临床实践指南：急性髓性白血病（2018.V1）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%99%BD%E8%A1%80%E7%97%85" target="_blank">有关白血病更多指南</a></ul>, tagList=[TagDto(tagId=4136, tagName=唐氏综合征), TagDto(tagId=76770, tagName=一过性白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6463, appHits=76, showAppHits=0, pcHits=4948, showPcHits=3363, likes=116, shares=3, comments=4, approvalStatus=1, publishedTime=Mon Jun 25 21:45:56 CST 2018, publishedTimeString=2018-06-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 25 21:45:56 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:47:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 BSH指南：唐氏综合征一过性白血病的调查和管理)])
2018 BSH指南：唐氏综合征一过性白血病的调查和管理
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=330844, encodeId=1a0233084468, content=学习了.特别少见的病历, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b61638750, createdName=1dd9d486m37(暂无匿称), createdTime=Wed Jul 11 13:36:57 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327023, encodeId=4b0f32e0239b, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jun 26 00:40:32 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327010, encodeId=5a7432e01096, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:14 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327001, encodeId=a3a432e00151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Mon Jun 25 23:02:28 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-07-11 1dd9d486m37(暂无匿称)

    学习了.特别少见的病历

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=330844, encodeId=1a0233084468, content=学习了.特别少见的病历, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b61638750, createdName=1dd9d486m37(暂无匿称), createdTime=Wed Jul 11 13:36:57 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327023, encodeId=4b0f32e0239b, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jun 26 00:40:32 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327010, encodeId=5a7432e01096, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:14 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327001, encodeId=a3a432e00151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Mon Jun 25 23:02:28 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-26 phoebeyan520

    学习了.谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=330844, encodeId=1a0233084468, content=学习了.特别少见的病历, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b61638750, createdName=1dd9d486m37(暂无匿称), createdTime=Wed Jul 11 13:36:57 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327023, encodeId=4b0f32e0239b, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jun 26 00:40:32 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327010, encodeId=5a7432e01096, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:14 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327001, encodeId=a3a432e00151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Mon Jun 25 23:02:28 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 清风拂面

    谢谢分享学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=330844, encodeId=1a0233084468, content=学习了.特别少见的病历, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b61638750, createdName=1dd9d486m37(暂无匿称), createdTime=Wed Jul 11 13:36:57 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327023, encodeId=4b0f32e0239b, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jun 26 00:40:32 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327010, encodeId=5a7432e01096, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:14 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327001, encodeId=a3a432e00151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Mon Jun 25 23:02:28 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 329523732

    不错

    0